David Thomas Evans - 15 May 2026 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 May 2026, 16:21:59 UTC
Prior SEC filing
16 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nick Lynton, Attorney-in-Fact

Key filing fact

David Thomas Evans filed Form 4 for Cardlytics, Inc. (CDLX) on 19 May 2026.

Key facts

  • This page summarizes David Thomas Evans's Form 4 filing for Cardlytics, Inc. (CDLX).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 19 May 2026, 16:21.

Change

  • Previous filing in this sequence was filed on 16 Jan 2026.
  • Current net transaction value: +$129,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001730451 Primary reporting owner

Evans David Thomas

Relationship
Chief Financial Officer
Address
C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 4100, ATLANTA
Signature
/s/ Nick Lynton, Attorney-in-Fact
Signature date
19 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDLX transaction

Common Stock

Purchase

Transaction value
$97,350
Shares
+150,000
Change %
+127%
Price
$0.6490
Shares after
267,930
Date
15 May 2026
Ownership
Direct
Footnotes
F1
CDLX transaction

Common Stock

Purchase

Transaction value
$31,650
Shares
+50,000
Change %
+19%
Price
$0.6330
Shares after
317,930
Date
18 May 2026
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.639 to $0.650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1).

Footnote F2

The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.627 to $0.639, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .